| Recruiting | Trial to Assess Chelation Therapy in Critical Limb Ischemia Critical Limb Ischemia, Diabetes | Phase 3 | 2019-03-19 |
| Withdrawn | Prolonged Gadolinium Retention After MRI Imaging Heavy Metal Toxicity | Phase 4 | 2017-07-01 |
| Completed | Trial to Assess Chelation Therapy 2 Diabetes, Myocardial Infarction | Phase 3 | 2016-10-01 |
| Completed | Chelation Therapy in Diabetic Patients With Critical Limb Ischemia Critical Limb Ischemia, Peripheral Arterial Disease | EARLY_Phase 1 | 2015-08-01 |
| Unknown | The Effect of a 36-week Tablet-based Intervention on Multiple Domains in Older Adults With Mild Cognitive Impa Mild Cognitive Impairment | N/A | 2014-03-01 |
| Completed | Contrast Nephropathy and Nitrates Contrast Induced Nephropathy | Phase 4 | 2013-06-01 |
| Completed | Temozolomide Plus Bevacizumab in Patients With Metastatic Melanoma Involving the Central Nervous System Melanoma | Phase 2 | 2009-11-01 |
| Completed | Miracle Fruit Powder for the Treatment of Taste Alterations Secondary to Chemotherapy Taste, Altered, Dysgeusia | EARLY_Phase 1 | 2008-08-18 |
| Completed | Clinical Applications of Domperidone in Patients With Delayed Gastric Emptying Digestive System Disease | N/A | 2007-12-01 |
| Completed | Phase II Trial of Abraxane and Capecitabine in Metastatic Colon Cancer (COL 01) Colorectal Cancer | Phase 2 | 2007-09-01 |
| Completed | A Phase II Trial OF Carboplatin, ABI-007 (Abraxane) And Sorafenib (BAY 43-9006) in Metastatic Melanoma Malignant Melanoma | Phase 2 | 2007-05-01 |
| Completed | Phase II Trial of (IL-2) With Priming and (GM-CSF) in Patients With Advanced Melanoma Malignant Melanoma | Phase 2 | 2006-02-01 |
| Completed | Study of Oxaliplatin and Gemcitabine With or Without Bevacizumab to Treat Advanced Non-Small Cell Lung Cancer Non-Small Cell Lung Cancer | Phase 2 | 2004-06-01 |
| Completed | Trial to Assess Chelation Therapy (TACT) Coronary Artery Disease | Phase 3 | 2003-09-01 |
| Completed | Combined Modality Therapy With Growth Factor Support in Locally Advanced Non-small Cell Lung Cancer (NSCLC) Unresectable Locally Advanced NSCLC | Phase 2 | 2003-09-01 |
| Completed | Subcutaneous Amifostine Safety Study Head and Neck Cancer, Lung Cancer, Lymphoma | Phase 4 | 2002-01-01 |
| Completed | Mode Selection Trial in Sinus Node Dysfunction (MOST) Arrhythmia, Cardiovascular Diseases, Heart Diseases | Phase 3 | 1995-06-01 |